Momentum Grows For Novel Oral Anticoagulants Out To Replace Warfarin
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Betrixaban, and where it fits in the crowded development space of novel anticoagulants, came into sharper focus with the release of new Phase II data at the American College of Cardiology annual meeting